Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one

Gregory M Peterson, Jackson Thomas, Kwang C Yee, Sam Kosari, Mark Naunton, Inger H Olesen

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one'. Together they form a unique fingerprint.

Medicine & Life Sciences